Navigation Links
CBI Announces the Agenda for Their West Coast Forum on Clinical Supply Chain Management
Date:9/11/2009

WOBURN, Mass., Sept. 11 /PRNewswire/ -- The Center for Business Intelligence (CBI) is pleased to announce the full agenda for their 2nd West Coast Forum on Clinical Supply Chain Management. The conference takes place in Burlingame, CA, on October 28-29, 2009.

Chaired by Frank Reale (Worldwide Regulatory Coordination and Clinical Supplies, Merck), discussion throughout the conference promises to be both interactive and informative. Particular attention will be paid to actionable takeaways that can have a near-immediate impact on the efficiency of clinical supply chain operations.

The speaking faculty for the event is second to none. Drawing largely from the West Coast, the conference features 13 industry perspectives from organizations including Merck, Schering-Plough, Elan Pharmaceuticals, Cerexa, Santen, Celgene, Facet Biotech, ImClone Systems, MedImmune, Medivation and Talecris. Attendees will network with peers and learn to:

  • Avoid re-labeling costs and risks by using IVR/IWR technology for IMP expiry date management
  • Save money and reduce waste with increased accuracy in supply forecasting
  • Satisfy clinical supply needs regardless of complex sourcing challenges
  • Prevent delays by avoiding or coping with import/export violations
  • Ensure the successful and timely delivery of clinical supplies to sites around the globe
  • Create contingency plans for natural disasters, lost lots, etc.

The conference is the industry's best opportunity to walk away with the latest insights on clinical supply chain management. For more information on the conference or to view the entire agenda, please visit cbinet.com/supplywest.

About CBI:

A subsidiary of Advanstar Communications, The Center for Business Intelligence is dedicated to developing market-driven, unbiased conferences in the pharmaceutical, biotechnology, and medical device industries. CBI's conferences provide a unique platform for concrete, real-life examples that can be applied to any organization immediately, significantly impacting both costs and revenue. For more information, please visit cbinet.com.

For additional information or media inquiries, please contact: Emily Forest, Marketing Manager, at 339-298-2156.

This release was issued through eReleases(TM). For more information, visithttp://www.ereleases.com.


'/>"/>
SOURCE Center for Business Intelligence
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. CryoLife Announces First Clinical Use of BioFoam(R)
2. Martek Announces Settlement of Patent Dispute with Capsugel France
3. Mpex Pharmaceuticals Announces Positive Phase 2b Clinical Trial Results with Aeroquin(R) (MP-376) Treatment in Cystic Fibrosis Patients
4. Esperance Pharmaceuticals Announces Initiation of Clinical Studies of its Novel Membrane-disrupting Agent, EP-100, in Patients with Cancer
5. SEQUENOM Announces Partnership With GeneWorks for Sales & Marketing of MassARRAY Systems and Applications in Australia
6. Misonix Announces New Sales Agency Agreement for Middle East, India and Pakistan
7. Simbionix USA Corporation Announces the Appointment of Mr. Paul Jensen as General Manager for its Growing eLearning and Content Business
8. Biovista Inc. Announces Positive Efficacy Results in a Pre-clinical Trial of its BVA-201 Repositioned Drug for Multiple Sclerosis
9. PharmaNet Development Group Provides Financial Update and Announces Geographic Expansion
10. Encorium Group, Inc. Announces New Business Awards of $8.7 Million, Including Swine Flu (Influenza A H1N1 virus) Vaccine Trial Win;
11. Medivation Announces Participation in Upcoming Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/17/2017)... , Jan. 17, 2017  An international ... of Medicine and St. Boniface Hospital Albrechtsen Research ... peripheral neuropathy, an unmet health need affecting nearly ... Journal of Clinical Investigation, their results identify small ... prevent and reverse neuronal injury in animal models ...
(Date:1/17/2017)... LEXINGTON, Mass. , Jan. 17, 2017   ... clinical stage biopharmaceutical company developing innovative inhaled therapies to ... candidate for treating fungal infections in the lungs of ... Infectious Disease Product" (QIDP) by the U.S. Food & ... , which is designed to speed the development of ...
(Date:1/17/2017)... 17, 2017  Only nine percent of U.S. consumers ... while only 16 percent believe health insurance companies do, ... 36 percent of U.S. adults believe health care providers ... compared to hospitals (23%). "We are in ... Wendy Salomon , vice president of reputation management and ...
(Date:1/17/2017)... ... January 17, 2017 , ... Pono Ola , a mind-body wellness firm ... today the official launch of its much-anticipated Pono Board: a re-invented fitness and anti-fatigue ... development for over a year, the patented Pono Board is the world’s only exercise ...
Breaking Biology Technology:
(Date:1/12/2017)... 12, 2017  Trovagene, Inc. (NASDAQ: TROV ... today announced that it has signed agreements with seven ... the Middle East for commercialization ... the first wave of international distribution agreements for Trovagene,s ... samples. The initial partners will introduce Trovagene,s ...
(Date:1/11/2017)... 2017  Michael Johnson, co-founder of Visikol Inc. a company originally ... been named to the elite "Forbes 30 Under 30" list in ... people in 20 fields nationwide to be recognized as a leader ... were selected. ... is currently a PhD candidate at Rutgers University. ...
(Date:1/4/2017)... -- For the thousands of attendees at this year,s International Consumer Electronics Show ... biometric measurement devices and services, will be featuring its new line of ... Medical,s special CES Exhibit Suite , the new upper arm and ... WellnessConnected product platform.  Continue ... ...
Breaking Biology News(10 mins):